CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression. [electronic resource]
Producer: 20180507Description: 1213-1221 p. digitalISSN:- 1433-8726
- Androgen Antagonists -- pharmacology
- Anilides -- pharmacology
- Blotting, Western
- Casein Kinase II -- antagonists & inhibitors
- Cell Line, Tumor
- Drug Resistance, Neoplasm -- drug effects
- Genetic Variation
- Humans
- Male
- NF-kappa B -- drug effects
- NF-kappa B p50 Subunit -- drug effects
- Naphthyridines -- pharmacology
- Nitriles -- pharmacology
- Phenazines
- Prostatic Neoplasms, Castration-Resistant -- genetics
- RNA, Messenger -- drug effects
- Receptors, Androgen -- drug effects
- Signal Transduction
- Tosyl Compounds -- pharmacology
- Transcription Factor RelA -- drug effects
- Tumor Stem Cell Assay
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.